Thymidylate synthase and dihydropyrimidine dehydrogenase expression levels are associated with response to S-1 plus carboplatin in advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

Thymidylate synthase and dihydropyrimidine dehydrogenase expression levels are associated with response to S-1 plus carboplatin in advanced non-small cell lung cancer

Published:2011-07 Issue:1 Volume:73 Page:103-109
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Takeda Masayuki,Okamoto Isamu,Hirabayashi Naoko,Kitano Mami,Nakagawa Kazuhiko

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference33 articles.

1. Lung cancer;Hoffman;Lancet,2000

2. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N Engl J Med,2002

3. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy;Olaussen;N Engl J Med,2006

4. BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer;Taron;Hum Mol Genet,2004

5. Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer;Reynolds;J Clin Oncol,2009

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II trial of daily S‐1 combined with weekly irinotecan in previously treated patients with advanced or recurrent squamous cell lung cancer: North Japan lung cancer group 1101;Thoracic Cancer;2023-08-17

2. Efficacy of S‐1 after pemetrexed in patients with non‐small cell lung cancer: A retrospective multi‐institutional analysis;Thoracic Cancer;2021-07-13

3. Intratumoral gene expression of dihydrofolate reductase and folylpoly-c-glutamate synthetase affects the sensitivity to 5-fluorouracil in non-small cell lung cancer;Discover Oncology;2021-06-25

4. Phase I/II Study of Docetaxel and S-1 in Previously-Treated Patients with Advanced Non-Small Cell Lung Cancer: LOGIK0408;Journal of Clinical Medicine;2019-12-12

5. A potential novel drug combination for adjuvant therapy in lung cancer: reflections on an early phase of clinical development;Journal of Chemotherapy;2019-08-18